AMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair, today announced that the Company will host a conference call and live webcast on Monday, June 15, 2015, at 10:00 AM EDT (4:00 PM CEST) to review highlights from the two oral presentations on the luspatercept clinical trials in myelodysplastic syndromes and beta-thalassemia given at the 20th Congress of the European Hematology Association.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
